Principales conclusions et analyse des parts de marché des thérapies ciblées par néoantigènes d'ici 2025-2031
Neoantigen Targeted Therapies Market Report Analysis
Neoantigen Targeted Therapies Market
-
CAGR (2023 - 2031)XX% -
Market Size 2023
US$ XX million -
Market Size 2031
US$ XX Million

Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- Achilles Therapeutics
- Advaxis, Inc.
- Frame Cancer Therapeutics
- Genocea Biosciences, Inc.
- Gradalis, Inc.
- Gritstone Oncology
- Immunicum AB
- Iovance Biotherapeutics, Inc.
- Medigene
Regional Overview

- Amérique du Nord
- Europe
- Asie-Pacifique
- Amérique du Sud et centrale
- Moyen-Orient et Afrique
Market Segmentation

- thérapie combinée et monothérapie

- hôpitaux et cliniques
- instituts de recherche médicale et autres utilisateurs finaux

- Amérique du Nord
- Europe
- Asie-Pacifique
- Amérique du Sud et Centrale